Niflumic Acid

10/31/1985 - "[Niflumic acid in otorhynolaryngologic inflammation in childhood. "
01/01/2019 - "In this study, we used the steroid-induced rat model of PcP to evaluate inflammation and mucus progression, and tested the effect of niflumic acid (NFA), a fenamate-type drug with potent CLCA1 blocker activity, in decreasing Pneumocystis-associated immunopathology. "
01/01/1985 - "Use of acute phase protein changes to assess the effects of a nonsteroidal antiinflammatory drug (niflumic acid) on the inflammation process induced by limited plastic surgery."
01/01/1990 - "The combination of Nifluril with antibiotic therapy gave significantly greater relief from abnormalities of the tympanic membrane (after two days treatment), inflammation of the throat and nasal congestion than did antibiotic therapy alone. "
06/01/1996 - "In rats without peripheral inflammation the NSAID, flunixin, a niflumic acid derivative, had only a small effect that was not dose-dependent. "

12/31/2018 - "Niflumic acid, a drug used for joint and muscular pain, affected Ca²⁺ signaling in different models. "
05/01/1974 - "[Treatment of arthrotic pain through short cures of niflumic acid]."
06/01/2019 - "Niflumic acid is used to treat inflammatory rheumatoid diseases, pain, and fever. "
01/01/1990 - "Clinical assessments before and after 2 and 4 days of treatment showed that there was faster resolution of fever, pain, adenopathy, pharyngeal congestion and dysphagia, and improved patient comfort in the niflumic acid group. "
06/01/2015 - "Morniflumate, the ß-morpholinoethyl ester of niflumic acid, is a member of the fenamate family of NSAIDs indicated for the treatment of inflammatory conditions (with or without pain) affecting airways, the ENT system, urogenital tract and the osteoarticular system. "

06/10/2023 - "Brij® integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In vitro characterization, ex vivo permeability assessment, and in vivo study."
06/10/2023 - "The objective of this research was to encapsulate niflumic acid (NA), a non-steroidal anti-inflammatory drug into Brij® integrated bilosomes (BIBs) for effective treatment of osteoarthritis through transdermal delivery. "
07/01/1976 - "Niflumic acid in the management of rheumatoid and osteoarthritis."
01/01/1973 - "Niflumic acid in osteoarthrosis. "
01/01/1973 - "Niflumic acid in osteoarthrosis. "

12/01/2016 - "Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain."
12/01/2016 - "With this background, the present study was aimed to investigate the protective effect of niflumic acid, a TRPV1 modulator, on stavudine (STV)-induced neuropathic pain in rats. "
08/01/2017 - "Effects of niflumic acid on γ-aminobutyric acid-induced currents in isolated dorsal root ganglion neurons of neuropathic pain rats."
12/01/2016 - "Niflumic acid restored core and associated symptoms of peripheral neuropathy by suppressing oxidative-nitrosative stress, inflammatory cytokines (TNF-α, IL-1β) and TRPV1 level in stavudine-induced neuropathic pain in rats. "

06/01/2019 - "Niflumic acid is used to treat inflammatory rheumatoid diseases, pain, and fever. "
01/01/1990 - "Clinical assessments before and after 2 and 4 days of treatment showed that there was faster resolution of fever, pain, adenopathy, pharyngeal congestion and dysphagia, and improved patient comfort in the niflumic acid group. "
01/01/1990 - "A double-blind, placebo-controlled study was carried out in 231 adult patients suffering from acute diffuse pharyngitis or acute tonsillitis with fever and dysphagia to assess the effectiveness of niflumic acid combined with standard antibiotic therapy in relieving pain and inflammation. "